China · Delayed Price · Currency is CNY Shanghai Medicilon Statistics
Total Valuation
SHA:688202 has a market cap or net worth of CNY 12.43 billion. The enterprise value is 12.17 billion.
| Market Cap | 12.43B |
| Enterprise Value | 12.17B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688202 has 131.55 million shares outstanding. The number of shares has increased by 2.22% in one year.
| Current Share Class | 131.55M |
| Shares Outstanding | 131.55M |
| Shares Change (YoY) | +2.22% |
| Shares Change (QoQ) | +3.36% |
| Owned by Insiders (%) | 42.15% |
| Owned by Institutions (%) | 11.70% |
| Float | 74.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.98 |
| PB Ratio | 6.20 |
| P/TBV Ratio | 7.15 |
| P/FCF Ratio | 698.33 |
| P/OCF Ratio | 75.17 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 683.79 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.84 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 6.07 |
| Debt / FCF | 12.52 |
| Interest Coverage | -15.55 |
Financial Efficiency
Return on equity (ROE) is -5.06% and return on invested capital (ROIC) is -4.05%.
| Return on Equity (ROE) | -5.06% |
| Return on Assets (ROA) | -1.52% |
| Return on Invested Capital (ROIC) | -4.05% |
| Return on Capital Employed (ROCE) | -3.30% |
| Weighted Average Cost of Capital (WACC) | 8.29% |
| Revenue Per Employee | 552,767 |
| Profits Per Employee | -41,265 |
| Employee Count | 2,504 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 7.47 |
Taxes
| Income Tax | -7.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.69% in the last 52 weeks. The beta is 0.76, so SHA:688202's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +17.69% |
| 50-Day Moving Average | 89.79 |
| 200-Day Moving Average | 69.52 |
| Relative Strength Index (RSI) | 44.43 |
| Average Volume (20 Days) | 7,632,124 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688202 had revenue of CNY 1.38 billion and -103.33 million in losses. Loss per share was -0.77.
| Revenue | 1.38B |
| Gross Profit | 322.67M |
| Operating Income | -69.40M |
| Pretax Income | -110.83M |
| Net Income | -103.33M |
| EBITDA | 24.54M |
| EBIT | -69.40M |
| Loss Per Share | -0.77 |
Balance Sheet
The company has 481.37 million in cash and 222.71 million in debt, with a net cash position of 258.67 million or 1.97 per share.
| Cash & Cash Equivalents | 481.37M |
| Total Debt | 222.71M |
| Net Cash | 258.67M |
| Net Cash Per Share | 1.97 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 14.89 |
| Working Capital | 653.23M |
Cash Flow
In the last 12 months, operating cash flow was 165.30 million and capital expenditures -147.51 million, giving a free cash flow of 17.79 million.
| Operating Cash Flow | 165.30M |
| Capital Expenditures | -147.51M |
| Depreciation & Amortization | 93.95M |
| Net Borrowing | -266.76M |
| Free Cash Flow | 17.79M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 23.31%, with operating and profit margins of -5.01% and -7.47%.
| Gross Margin | 23.31% |
| Operating Margin | -5.01% |
| Pretax Margin | -8.01% |
| Profit Margin | -7.47% |
| EBITDA Margin | 1.77% |
| EBIT Margin | -5.01% |
| FCF Margin | 1.29% |
Dividends & Yields
SHA:688202 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.22% |
| Shareholder Yield | -2.22% |
| Earnings Yield | -0.83% |
| FCF Yield | 0.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |